NCT06494514View on ClinicalTrials.gov

NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2027

Conditions
Locally Advanced Pancreatic Cancer
Interventions
DRUG

nal-IRI+Oxaliplatin+5-FU/LV+PD-1

These drugs are given on d1, d15, 28 days as one cycle. 6-6 treatment cycles. SBRT is performed in third cycles.

DRUG

Gemcitabine + albumin-paclitaxel+PD-1

These drugs are given on d1, d8, 21 days as one cycle. 6-6 treatment cycles. SBRT is performed in third cycles.

Trial Locations (2)

025

NOT_YET_RECRUITING

FirstNanjingMU, Nanjing

RECRUITING

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing

All Listed Sponsors
lead

Du Juan

OTHER